Skip to main content

Published works by Celeste Letourneau

LEX-AR-RX3V5XVT · complete body of work · page 1 of 1 · 8 works

Published works

FDA Announces Final Guidance on Clinical Decision Support Software
Health Industry Washington Watch · September 28, 2022
LEX-WK-CDSN4N84
United States federal and state rules and regulations during public health emergencies: navigating novel coronavirus
Life Sciences Legal Update · February 13, 2020
LEX-WK-5N1GSBZY
NIH Finalizes New Drug and Device Clinical Trial Reporting Requirements
Health Industry Washington Watch · October 3, 2016
LEX-WK-G98EBJA1
Navigating the Regulatory Issues of 3D Printing
Life Sciences Legal Update · March 16, 2016
LEX-WK-V81333P4
CMS Seeks Public Comment on its Imposition of CMPs for Noncompliance with Medicare Secondary Payer Reporting Requirements; Opportunity for Clinical Trial Sponsors to Request Discretion
Life Sciences Legal Update · January 29, 2014
LEX-WK-RBXZQ20Q
FDA Draft Guidance on Safety Data Collection for Late Stage Premarket & Postmarket Investigations
Health Industry Washington Watch · March 14, 2012
LEX-WK-PDA2ZFX0
CMS and FDA Announce Parallel Review Pilot Program
Life Sciences Legal Update · October 12, 2011
LEX-WK-61FX0BYX
Prospects Unclear for CMS/FDA Proposed Parallel Review of Medical Products
Life Sciences Legal Update · August 2, 2011
LEX-WK-7FZ3PNN0